NEWS & MEDIA

PRESS RELEASES NEWS & PERSPECTIVES EXPERT PERSPECTIVES MEDIA RESOURCES

PRESS RELEASES

09-19-2023

Kura Oncology to Participate in Cantor Global Healthcare Conference 2023
08-14-2023

Kura Oncology Appoints Brian Powl as Chief Commercial Officer
08-03-2023

Kura Oncology Reports Second Quarter 2023 Financial Results
VIEW ALL

NEWS & PERSPECTIVES

Year:

  • All
  • 2023
  • 2022
  • 2021
  • 2020

Type:

  • All
  • Awards
  • Kura Kommentary
  • Life at Kura
  • Media Coverage

Awards

2023 Scrip Awards Best Oncology R&D Advance

Awards

2023 Scrip Awards Executive of the Year – Developmental Stage Companies: Stephen Dale, M.D.

Awards

PharmaVoice 100 Top Industry Leaders: Teresa Bair, J.D.

Kura Kommentary

CEO Troy Wilson On Giving Back: Empowering Young Minds to Explore Life Sciences

Awards

San Diego Business Journal Leaders of Influence in Life Science 2023 Honorees

Awards

San Diego Business Journal CEO of the Year Awards 2023 Finalists

Kura Kommentary

World Medical Innovation Forum Panel on The Innovation Gap: The Promise of Precision Oncology for Liquid Tumors

Kura Kommentary

What pharma can teach biotech about the life cycle management of a drug

Kura Kommentary

Kura Oncology 2022 Annual Report

Awards

The Medicine Maker Power List 2023: Francis Burrows

Life at Kura

The History and Culture of Kura

Media Coverage

Navigating Dose Optimization Requirements as a Small Biotech

Media Coverage

On the Prickly Issues Facing the Menin Inhibitors

Awards

SDUT San Diego Top Workplaces 2022

Awards

PharmaVoice 100 Innovators: Dr. Stephen Dale

Media Coverage

Liquid Biopsies Guide the Development of Cancer Drugs

Life at Kura

COO Kathy Ford on What Makes Kura a Top Workplace

Awards

SDUT San Diego Top Workplaces 2021

Media Coverage

FDA’s Renewed Focus on Oncology Dosing Spooks Investors, but Companies Say They’re Ready

Media Coverage

Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC with HRAS Mutations

Media Coverage

Is This the Dawn of Precision Oncology in Head and Neck Cancer?

Kura Kommentary

CEO Troy Wilson on Sailing Through the Storm: Lessons from the Pandemic

Awards

PharmaVoice 100: Innovator’s Journey

Media Coverage

Biotech Strategy Blog Building walls versus building Cathedrals

Awards

PharmaVoice 100: Entrepreneurs

Media Coverage

BIO: Kura Oncology CEO Wilson on the power of biotech in the quest beyond KRAS

Kura Kommentary

CEO Troy Wilson on Navigating a Clinical Stage Biopharmaceutical Company Through the Pandemic
Load More

EXPERT PERSPECTIVES ON AML AND ZIFTOMENIB CLINICAL TRIALS

Amir T. Fathi, MD

Dr. Amer Zeidan, MBBS, MHS

MEDIA RESOURCES

Essential assets such as logos and images related to Kura Oncology.

VIEW ALL

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

© 2023 Kura Oncology, Inc. All Rights Reserved | Terms of Use | Privacy Policy